From: Lifetime survival and medical costs of lung cancer: a semi-parametric estimation from South Korea
Number of patients (%) | Surgery | Surgery+CTx/RTx | CTx/RTx | BSC | Total |
---|---|---|---|---|---|
Total | 426 (14.6) | 296 (10.1) | 1405 (48.1) | 792 (27.1) | 2919 (100.0) |
Males | 313 (73.5) | 221 (74.7) | 1135 (80.8) | 611 (77.2) | 2280 (78.1) |
Age (years) | |||||
Mean (SE) | 63.7 (8.9) | 62.1 (8.3) | 65.8 (8.6) | 73.2 (7.7) | 67.1 (9.2) |
Median (IQR) | 64.5 (13.0) | 62.0 (12.0) | 67.0 (12.0) | 74.0 (10.0) | 68.0 (13.0) |
Year at diagnosis | |||||
2004 | 58 (13.6) | 30 (10.1) | 171 (12.2) | 132 (16.7) | 391 (13.4) |
2005 | 46 (10.8) | 34 (11.5) | 195 (13.9) | 105 (13.3) | 380 (13.0) |
2006 | 44 (10.3) | 38 (12.8) | 197 (14.0) | 105 (13.3) | 384 (13.2) |
2007 | 59 (13.9) | 54 (18.2) | 210 (15.0) | 109 (13.8) | 432 (14.8) |
2008 | 75 (17.6) | 50 (16.9) | 195 (13.9) | 124 (15.7) | 444 (15.2) |
2009 | 72 (16.9) | 43 (14.5) | 204 (14.5) | 98 (12.4) | 417 (14.3) |
2010 | 72 (16.9) | 47 (15.9) | 233 (16.6) | 119 (15.0) | 471 (16.1) |
Smoking status | |||||
Missing | 5 (1.2) | 2 (0.7) | 22 (1.6) | 17 (2.2) | 46 (1.6) |
Non-smoker | 216 (50.7) | 148 (50.0) | 613 (43.6) | 404 (51.0) | 1381 (47.3) |
Smokerb | 205 (48.1) | 146 (49.3) | 770 (54.8) | 371 (46.8) | 1492 (51.1) |
Charlson comorbidity patient score | |||||
Mean (SE) | 2.3 (1.3) | 2.1 (1.2) | 2.3 (1.3) | 2.6 (1.4) | 2.3 (1.3) |
Median (IQR) | 2.0 (2.0) | 2.0 (2.0) | 2.0 (2.0) | 2.0 (3.0) | 2.0 (2.0) |